Verily

See the following -

Boston Scientific’s Connected Patient Challenge: Big Data Takes Center Stage

Brad Perriello | Mass Device | March 10, 2017

Big data, artificial intelligence and patient-engagement technologies were among the systems featured at yesterday’s Connected Patient Challenge hosted by Boston Scientific at Google’s Cambridge, Mass. facility. The Shark Tank–style event featured 6 companies competing for a chance to work with Boston Scientific to develop their proposed products or systems...

Read More »

Broad Institute and Verily partner with Microsoft to accelerate the next generation of the open source Terra platform for health and life science research

Press Release | Microsoft, Broad Institute, Verily | January 11, 2021

On Monday, Broad Institute of MIT and Harvard, Verily, an Alphabet company, and Microsoft Corp. announced a strategic partnership to accelerate new innovations in biomedicine through the Terra platform. Terra, originally developed by Verily and the Broad Institute, is a secure, scalable, open-source platform for biomedical researchers to access data, run analysis tools and collaborate. Terra is actively used by thousands of researchers every month to analyze data from millions of participants in important scientific research projects.

Read More »

Cardiologist Eric Topol on Why We Need to Map the Human Body and “Go Deep” with Big Data

Press Release | Stanford Medicine | May 25, 2017

This year’s Big Data in Biomedicine conference included a passionate talk from cardiologist Eric Topol, MD, of The Scripps Research Institute. Topol, who has been named one of the most influential physician leaders in the United States, described in gripping detail what’s wrong with medical care today and why we need to move forward to the kind of individualized medicine that can make for healthier individuals and healthier populations...

Read More »

Digital health round-up: bioelectronics are closer than you think

Marco Ricci | Pharma Phorum | September 8, 2017

Towards the end of last year, Google’s life sciences division Verily and GlaxoSmithKline co-founded Galvani Bioelectronics to develop medicines that harness electrical signals in the body to treat chronic diseases like asthma, arthritis and even gastrointestinal diseases. At the time, the unveiling of Galvani felt like a new frontier in medicine and, though somewhat difficult to comprehend, something that could genuinely change the lives of millions of people worldwide...

Read More »

How AI, Twitter And Digital Volunteers Are Transforming Humanitarian Disaster Response

Katie Collins | Wired | September 30, 2013

On 24 September a 7.7-magnitude earthquake struck south-west Pakistan, killing at least 300 people. The following day Patrick Meier at the [QCRI] received a call from the UN [OCHA] asking him to help deal with the digital fallout -- the thousands of tweets, photos and videos that were being posted on the web containing potentially valuable information about the disaster. Read More »

How Google Plans to Reinvent Healthcare

Cheryl Swanson | The Motley Fool | September 3, 2016

Glucose-monitoring contact lenses for diabetics, wrist computers that read diagnostic nanoparticles injected in the blood stream, implantable devices that modify electrical signals that pass along nerves, medication robots, human augmentation, human brain simulation -- the list goes on. That's not an inventory of improbable CGI effects from the latest sci-fi movie, it's a list of initiatives being tackled by Alphabet's Google Life Sciences research unit, recently rebranded Verily...

Read More »

Obama Administration Announces Key Actions to Accelerate Precision Medicine Initiative

Press Release | The White House | February 25, 2016

A year ago the President announced the launch of the Precision Medicine Initiative to accelerate a new era of medicine that delivers the right treatment at the right time to the right person, taking into account individuals’ health history, genes, environments, and lifestyles. Precision medicine is already transforming the way diseases like cancer and mental health conditions are treated. Molecular testing for cancer patients lets physicians and patients select treatments that improve chances of survival and reduce adverse effects...

Read More »